Calyx’s extensive experience and award-winning IRT solution optimizes randomization and clinical trial supply management (RTSM) processes to propel your development program forward.
You have a lot at stake. And you can’t entrust your randomization and trial supply management processes to just anyone. No matter the complexity of your protocol or supply chain, Calyx defines solutions that:
- Reduce trial risks
- Optimize supply chains
- Make mid-trial adaptations easier
- Increase start-up efficiency
- Boost productivity
- Improve data quality
Used in over 4,000 global clinical trials, Calyx's IRT takes the worry out of randomization and supply management—so you can concentrate on study success.
You have a lot at stake. And you can’t entrust your RTSM processes to just anyone. No matter the complexity of your protocol or supply chain, Calyx defines solutions that:
- Reduce trial risks
- Optimize supply chains
- Make mid-trial adaptations easier
- Increase start-up efficiency
- Boost productivity
- Improve data quality
Used in over 4,000 global clinical trials, Calyx's IRT (sometimes referred to as RTSM) takes the worry out of randomization and supply management—so you can concentrate on study success.
When it comes to randomization and clinical trial supply management, you need a provider with expertise to design a functional and flexible solution that ensures patient safety.
Calyx’s IRT experts ask the right questions to uncover the right solutions. We don’t shy away from complexity. No, in fact we race toward it to anticipate risks related to your supply chain and randomization and advise how to mitigate those risks.
The result? A solution that:
- Eliminates risk of unblinding or misdispensing
- Ensures an uninterrupted drug supply
- Reduces the overall cost of drug management
- Delivers balanced & unbiased randomization
- Adapts to varying site recruitment